Multi-omics experiments are increasingly commonplace in biomedical research, and add layers of complexity to experimental design, data integration, and analysis. R and Bioconductor provide a generic framework for statistical analysis and visualization, as well as specialized data classes for a variety of high-throughput data types, but methods are lacking for integrative analysis of multi-omics experiments. The MultiAssayExperiment software package, implemented in R and leveraging Bioconductor software and design principles, provides for the coordinated representation of, storage of, and operation on multiple diverse genomics data. We provide all of the multiple 'omics data for each cancer tissue in The Cancer Genome Atlas (TCGA) as ready-to-analyze MultiAssayExperiment objects, and demonstrate in these and other datasets how the software simplifies data representation, statistical analysis, and visualization. The MultiAssayExperiment Bioconductor package reduces major obstacles to efficient, scalable and reproducible statistical analysis of multi-omics data and enhances data science applications of multiple omics datasets.
INTRODUCTION
Multi-assay experiments collect multiple, complementary data types for a set of specimens. Bioconductor provides classes to ensure coherence between a single assay and patient data during data analysis, such as eSet and SummarizedExperiment. However, novel challenges arise in data representation, management, and analysis of multi-assay experiments (4) , that cannot be addressed by these or other single-assay data architectures. These include 1) coordination of different assays on, for example, genes, microRNAs, or genomic ranges, 2) coordination of missing or replicated assays, 3) sample identifiers that differ between assays, 4) re-shaping data to fit the variety of existing statistical and visualization packages, 5) doing the above in a concise and reproducible way that is amenable to new assay types and data classes.
The need for a unified data model for multi-omics experiments has been recognized in other projects, such as MultiDataSet (9) and CNAMet (10) . Our developments are motivated by an interest in bridging effective single-assay API elements, including endomorphic feature and sample subset operations, to multi-omic contexts of arbitrary complexity and volume (Supplemental Table 1 ). A main concern in our work is to allow data analysts and developers to simplify the management of both traditional in-memory assay stores for smaller datasets, and out-of-memory assay stores for very large data, in such formats as HDF5, tabix-indexed VCF, or Google BigTable.
MultiAssayExperiment provides data structures and methods for representing, manipulating, and integrating multi-assay genomic experiments.
It integrates an open-ended set of R and Bioconductor single-assay data classes, while abstracting the complexity of back-end data objects a sufficient set of data manipulation, extraction, and re-shaping methods to interface with most R/Bioconductor data analysis and visualization tools. We demonstrate its use by representing unrestricted data from TCGA as a single MultiAssayExperiment object per cancer type, and demonstrating greatly simplified multi-assay analyses with these and other public multi-omics datasets.
MATERIALS AND METHODS
MultiAssayExperiment https://bioconductor.org/packages/MultiAssayExperiment introduces a Bioconductor S4 class with three key components: 1) colData, a "primary" dataset containing patient or cell line-level characteristics such as pathology and histology, 2) ExperimentList, a list of results from complementary experiments, and 3) sampleMap, a map that relates these elements (Figure 1a ). ExperimentList data elements may be of any data class that has standard methods for basic subsetting (single square bracket `[`) and dimension names and sizes (`dimnames()` and `dim()`). Key methods for the MultiAssayExperiment class include:
1. A constructor function and associated validity checks that simplifies creating MultiAssayExperiment objects, while allowing for flexibility in representing complex experiments. 2. Subsetting operations allowing data selection by genomic identifiers or ranges, clinical/pathological variables, available complete data (subsets that include no missing values), and by specific assays.
Robust and intuitive extraction and replacement operations for components of the
MultiAssayExperiment. The MultiAssayExperiment API is based wherever possible on SummarizedExperiment while supporting heterogeneous multi-omics experiments. MultiAssayExperiment design, constructor, subsetting, extraction, and helper methods, as well as methods and code for the examples demonstrated here, are detailed in the Supplemental Methods.
RESULTS
The MultiAssayExperiment class and methods ( Table 1 ) provide a flexible framework for integrating and analyzing complementary assays on an overlapping set of samples. It integrates any data class that supports basic subsetting and dimension names, so that many data classes are supported by default without additional accommodations. The MultiAssayExperiment class (Figure 1a ) ensures correct alignment of assays and patients, provides coordinated subsetting of samples and features while maintaining correct alignment, and enables simple integration of data types to formats amenable to analysis by existing tools. Basic usage is outlined in Video 1 (https://youtu.be/w6HWAHaDpyk), and in the QuickStartMultiAssay vignette accompanying the package.
We coordinated over 300 assays on 19,000 specimens from 33 different cancers in The Cancer Genome Atlas, along with curated clinical data and published subtypes, and represented these as one MultiAssayExperiment per cancer type (Supplemental Table 3 ). These data objects link each assay to their patient of origin, allowing more straightforward selection of cases with complete data for assays of interest, and integration of data across assays and between assays and clinical data. We demonstrate applications of MultiAssayExperiment for visualizing the overlap in assays performed for adrenocortical carcinoma patients (Figure 1b) , confirming recently reported correlations between somatic mutation and copy number burden in colorectal cancer and breast cancer (Figure 1c) , identifying a SNP/methylation quantitative trait locus using remotely stored tabix-indexed VCF files for the 1000 genomes project (Figure 1d) , calculating correlations between copy number, gene expression, and protein expression in the NCI-60 cell lines (Supplemental Figure 3) , and multi-assay gene set analysis for ovarian cancer (Supplemental Figures 1-2) . Demonstrative code chunks and fully reproducible scripts are given to demonstrate the simple and powerful flexibility provided by MultiAssayExperiment.
DISCUSSION
MultiAssayExperiment enables coordinated management management and extraction of complex multi-assay experiments and clinical data, with the same ease of user-level coding as for a single experiment. Its extensible design supports any assay data class meeting basic requirements, including out-of-memory representations for very large datasets. We have confirmed "out-of-the-box" compatibility with on-disk data representations, including the DelayedMatrix class via an HDF5 backend (11) , and the VcfStack class based on the GenomicFiles infrastructure. Future work will focus on higher-level visualization, integration, and analysis tools using MultiAssayExperiment as a building block. This project will receive longterm support as a necessary element of multi-assay data representation and analysis in Bioconductor. Concatenate an experiment MultiAssayExperiment Note. assay refers to a procedure for measuring the biochemical or immunological activity of a sample, e.g. RNA-seq, segmented copy number, and somatic mutation calls would be considered three different assays. experiment refers to the application of an assay to a set of samples. In general it is assumed that each experiment uses a different assay type, although an assay type may of course be repeated in different experiments. mae refers to a MultiAssayExperiment object. subject refers to patient, cell line, or other biological unit. observation refers to results of an assay, e.g. gene expression, somatic mutations, etc. features refer to measurements returned by the assays, labeled by row names or genomic ranges. (c) Extent of copy number alteration vs. somatic mutation burden. Cancer types with high levels of aneuploidy often show a positive correlation of mutation load and chromosomal instability (CIN) (12) , perhaps due to a higher tolerance of deleterious mutations, as shown here in orange for breast cancer. Tumors with a hypermutator phenotype rarely display extensive CIN, resulting in a negative correlation of mutation load and CIN in cancer types where hypermutation is common (shown in grey for colon adenocarcinoma). (d) Methylation Quantitative Trait Locus identified from an on-disk representation of Variant Call Format (VCF) files of the 1000 Genomes Project integrated with 450K methylation array data as a MultiAssayExperiment. FIgure 1 
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